Credit Suisse’s cbdMD YCBD Stock Holding History

Credit Suisse’s Portfolio YCBD Stock Details YCBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-89	Closed	-$93K	–	4571
2021 Q2	$93K	Buy	+89	New	+$106K	﹤0.01%	4373
2020 Q4	–	Sell	-82	Closed	-$59K	–	4466
2020 Q3	$59K	Buy	+82	New	+$78.2K	﹤0.01%	3952

Other funds holding YCBD

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LWM

Lionsbridge Wealth Management Jacksonville Beach, Florida $99.5M AUM 25.42% 1-Year Est. Return

Credit Suisse's YCBD Position: Q3 2021 in Review

Credit Suisse sold out of cbdMD (YCBD) in Q3 2021, closing a stake of 89 shares — an estimated $93K sold.

Credit Suisse first reported a position in YCBD in Q3 2020 and held it in 2 quarters. The position peaked at $93K in Q2 2021. 58 funds tracked by Wall St. Rank hold YCBD as of Q3 2021.

Credit Suisse reported no remaining cbdMD position as of Q3 2021 after selling out during the quarter.
Credit Suisse sold 89 cbdMD shares in Q3 2021, an estimated $93K.
Credit Suisse first reported a position in cbdMD in Q3 2020 and held it in 2 quarters.
Credit Suisse's cbdMD position peaked at $93K in Q2 2021.
58 funds tracked by Wall St. Rank held cbdMD as of Q3 2021.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.